Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reading ICARD: Interventions for Children With Attention and Reading Disorders
NCT01133847Phase 4Completed
- Sponsor
- UTHealth Houston
- Start
- Nov 2010
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by UTHealth Houston. Started Nov 2010; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01133847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01133847.